Targeting SEC61 complex to overcome resistance to immunotherapy in GBM
Description preview
Glioblastoma (GBM) is an incurable brain tumor with a median overall survival of less than 15 months. The recent
success of immunotherapy in extracranial malignancies has translated into trials for GBM. Despite its promise,
immunotherapy's clinical efficacy has yet to be shown for GBM. The resistance to immunotherapy in GBM is
multifactorial. To…
Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click